Understanding the Role of Immune Cells in the Tumor Microenvironment
8am EST | 1pm GMT | 2pm CET
Using the example of tumor-associated macrophages (TAMs), this webinar takes a closer look at immune cells in the tumor microenvironment (TME), helping us to gain a better understanding of how specific immune cell subtypes and their reprogramming may influence therapy efficiency.
Using the example of tumor-associated macrophages (TAMs), this webinar takes a closer look at immune cells in the tumor microenvironment (TME), helping us to gain a better understanding of how specific immune cell subtypes and their reprogramming may influence therapy efficiency.
Our first speaker, Dr. James Arnold, will focus on a TAM subset that can influence the immuno-modulatory effects of chemotherapy in cancer, highlighting how their structure and cell–cell communication moderate T-cell infiltration into tumors.
In the second half of the webinar, Dr. Aurélie Tchoghandjian will discuss her research into TAMs in glioblastoma, including how TAM phenotypes, spatiotemporal distribution and functions can be reprogrammed.
Attend this webinar to discover:
- The role of TAMs in solid cancers
- How suppression or activation of the immune response within the tumor microenvironment can impact immunotherapy effectiveness
- The power of multi-angle approaches, including imaging and cellular assays, in addressing the complexity of the TME
Speakers
Dr. James Arnold
Reader and Head of Tumor Immunology Group
King's College London
Dr. Aurélie Tchoghandjian
Research Fellow, Co-Head of the GlioME Team and Coordinator of the PETRA Network
CNRS
Brought to you by
Now Available on Demand!
